Owner Aventis Pharma S.A.

Inventors Chauvin, Josiane; Schwabe, Detlev; Becourt, Philippe

Agent Watermark

Pub. Number AU-B-2002329311

PCT Number PCT/FR02/02158

PCT Pub. Number WO2003/000225

Priority 01/08157 21.06.01 FR

Filing date 21 June 2002

Wipo publication date 8 January 2003

Acceptance publication date 1 February 2007

A61K 9/10 (2006.01) Medicinal preparations characterised by special physical form - Dispersions

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 31/43 (2006.01)

A61K 31/4704 (2006.01) - 2-Quinolinones, e.g. carbostyril

A61K 31/545 (2006.01) - Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula , e.g. cephalosporins, cefaclor, cephalexine

A61K 31/65 (2006.01) - Tetracyclines

A61K 31/7048 (2006.01)

A61K 47/04 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

A61K 47/18 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

A61K 47/32 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds

A61K 47/38 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Cellulose

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics